Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort

Joseph Nathan, Bayram Farisogullari, Nicholas Jones, Mohammad Ayoub, James Brown, Sarah Levy, James Brader, Ayse Ersoy, Blossom Israni, Mark Lloyd, Afzal Latheef, Diane Hill, Amybel Taylor, Darshani Arachchige, Hlaing Chitsu, Helen Linklater, Kunal Lather, Luke Gompels, Eman Elfar, Ritu Malaiya, Pedro M Machado, Patrick D W Kiely

Open source

DOI: 10.1093/rap/rkag024
Published: 2026
Container: Rheumatology Advances in Practice
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rap/rkag024,
  title = {Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort},
  author = {Joseph Nathan and Bayram Farisogullari and Nicholas Jones and Mohammad Ayoub and James Brown and Sarah Levy and James Brader and Ayse Ersoy and Blossom Israni and Mark Lloyd and Afzal Latheef and Diane Hill and Amybel Taylor and Darshani Arachchige and Hlaing Chitsu and Helen Linklater and Kunal Lather and Luke Gompels and Eman Elfar and Ritu Malaiya and Pedro M Machado and Patrick D W Kiely},
  year = {2026},
  journal = {Rheumatology Advances in Practice},
  doi = {10.1093/rap/rkag024},
  url = {https://doi.org/10.1093/rap/rkag024}
}

RIS

TY  - JOUR
TI  - Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort
AU  - Joseph Nathan
AU  - Bayram Farisogullari
AU  - Nicholas Jones
AU  - Mohammad Ayoub
AU  - James Brown
AU  - Sarah Levy
AU  - James Brader
AU  - Ayse Ersoy
AU  - Blossom Israni
AU  - Mark Lloyd
AU  - Afzal Latheef
AU  - Diane Hill
AU  - Amybel Taylor
AU  - Darshani Arachchige
AU  - Hlaing Chitsu
AU  - Helen Linklater
AU  - Kunal Lather
AU  - Luke Gompels
AU  - Eman Elfar
AU  - Ritu Malaiya
AU  - Pedro M Machado
AU  - Patrick D W Kiely
PY  - 2026
JO  - Rheumatology Advances in Practice
DO  - 10.1093/rap/rkag024
UR  - https://doi.org/10.1093/rap/rkag024
ER  -

APA

Nathan, J., Farisogullari, B., Jones, N., Ayoub, M., Brown, J., Levy, S., Brader, J., Ersoy, A., Israni, B., Lloyd, M., Latheef, A., Hill, D., Taylor, A., Arachchige, D., Chitsu, H., Linklater, H., Lather, K., Gompels, L., Elfar, E., Malaiya, R., Machado, P. M., & Kiely, P. D. W. (2026). Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort. Rheumatology Advances in Practice. https://doi.org/10.1093/rap/rkag024

Source records

crossref · retrieved 2026-09-26T11:13:55.391Z